DGMT - Tao Chen E07796 possible CDER funding Sequencing contract

The contract titled "DGMT - Tao Chen E07796 possible CDER funding Sequencing contract" is a forecast opportunity associated with the Food and Drug Administration (FDA). It pertains to sequencing services likely funded by the Center for Drug Evaluation and Research (CDER). The contract falls under the NAICS code 541714, which typically encompasses research and development related to biotechnology. Although specific details such as solicitation numbers, set-aside statuses, and performance locations are not provided, this opportunity is indicated to be under the FDA’s purview, suggesting a focus on biomedical or pharmaceutical research support. Key contacts include a program point of contact reachable via email at nctracquisitions@fda.hhs.gov and a contracting officer position not yet assigned. The contract announcement was posted on March 11, 2026, and is accessible through the Health and Human Services Office of Small and Disadvantaged Business Utilization’s industry opportunity forecast website. Potential bidders would need to prepare for a procurement related to advanced sequencing tasks, supporting regulatory evaluations conducted by CDER within the FDA framework.